The BGL Healthcare & Life Sciences Report highlights the emerging consolidation within dermatology services, which is being driven by a number of key factors including attractive sector dynamics, significant benefits to scale and operating sophistication, and growing investor appetite in the specialty.

BGL is one of the most active advisors to physician practices in the U.S. across virtually all specialties. We maintain an ongoing commitment to the dermatology sector through research, conference participation, and advisory work.  Our Healthcare & Life Sciences team recently advised in the sale of a sizable practice in the Southeast to a strategic acquirer.